ZHONGSHENGYAOYE

36Kr · Nov 13, 2025 at 09:56 PM

In half a day, the main funds increased their positions in the pharmaceutical and biotechnology sector while selling off the electronics sector

Zhitong · Oct 30, 2025 at 06:08 AM

ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10%

Zhitong · Oct 27, 2025 at 05:09 AM

ZHONGSHENGYAOYE: Subsidiary receives approval notice for the listing application of polyvinyl alcohol chemical raw materials

Zhitong · Sep 29, 2025 at 06:05 AM

ZHONGSHENGYAOYE's subsidiary has obtained ethical approval for the Phase III clinical trial of the innovative drug Anglatide granules

Zhitong · Aug 28, 2025 at 11:21 AM

ZHONGSHENGYAOYE released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, a year-on-year increase of 114.96%

Zhitong · Aug 27, 2025 at 04:46 AM

ZHONGSHENGYAOYE: The first participant has been enrolled in the Phase III clinical trial of RAY1225 injection for glycemic reduction